To understand the growing market potential for stem cell therapies, it is critical to consider the current landscape for stem cell clinical trials.
ClinicalTrials.gov is the global registry of publicly and privately supported clinical studies involving human patients. While not a comprehensive resource, it contains approximately three-quarters of registered cell therapy trials worldwide.
Below is a map showing the location of current stem cell clinical trials.
Map of Stem Cell Clinical Trials, by Geographical Region
“Hotspots” for Stem Cell Clinical Trial Activity
Clearly, North America (3057 trials) and Europe (1288 trials) are “hotspots” for stem cell clinical trial activity.
Among the North American trials, nearly all of them of them are occurring in the United States (2935).
The next most active region is East Asia, with has 611 stem cell clinical trials.
Below is a summary of stem cell trial activity, broken down by region of the world.
Stem Cell Clinical Trial Activity, by Geographical Region
- North America – 3057 Trials (54.97%)
- Europe – 1288 Trials (23.16%)
- East Asia – 611 Trials (10.99%)
- Rest-of-World – 605 Trials (10.88%)
This information is also presented graphically below.
Due to Japan’s supportive legislation for stem cell-based therapies, it will be fascinating to track how this distribution changes over the next several years.
As the world’s first and only market research firm specializing in the stem cell industry, you can be sure that we will keep you updated.
To learn more about clinical trial activity and its impact on the stem cell marketplace, view “Stem Cell Research Products – Opportunities, Tools, and Technologies.”